Oct 15, 2022 | Contract Manufacturing Agreement, MOA, MYJ1633, NK Immune Cell Therapy
Universiti Kebangsaan Malaysia (UKM) and NK Biocell Sdn. Bhd. inked a Memorandum of Agreement (MoA) at the Hospital Universiti Kebangsaan Malaysia (HUKM). As a result of this arrangement, UKM can produce MYJ1633, which is made up of NK cells and NK T cells (NKT Cell)....
